Search Login Register

abciximab (ReoPro) Summary

Description: a monoclonal antibody Fab fragment that blocks the platelet glycoprotein IIb/IIIa receptor & potently inhibits platelet aggregation; used in treatment of refractory unstable angina

Also Known As: ReoPro; CentoRx; Clotinab; Eli Lilly brand of abciximab; Lilly brand of abciximab Show All >>

Networked: 1049 relevant articles (121 outcomes, 302 trials/studies) for this Drug

Key Diseases for which abciximab is Relevant

  1. Myocardial Infarction : 38 outcomes 152 studies in 416 results
  2. Thrombosis (Thrombus) : 24 outcomes 28 studies in 196 results
  3. Hemorrhage : 18 outcomes 37 studies in 209 results
  4. Acute Coronary Syndrome : 11 outcomes 41 studies in 122 results
  5. Stroke (Strokes) : 7 outcomes 17 studies in 67 results
Show All >>

Drugs Related to abciximab

  1. Heparin (Liquaemin)
  2. Glycoproteins (Glycoprotein)
  3. Platelet Membrane Glycoprotein IIb
  4. tirofiban (Aggrastat)
  5. abciximab (ReoPro)
  6. clopidogrel (Plavix)
  7. reteplase
  8. Aspirin (Acetylsalicylic Acid)
  9. glucuronyl glucosamine glycan sulfate (Vessel)
  10. eptifibatide (Integrilin)
Show All >>

Therapies Related to abciximab

  1. Angioplasty (Angioplasty, Transluminal)
  2. Stents
  3. Thrombectomy
  4. Transplants (Transplant)
  5. Catheters
Show All >>

CureHunter Inc. provides medical information and specifically does NOT provide medical advice.
© Copyright 2003-2016 CureHunter Inc., MeSH copyright NLM, Journal Articles copyright original owners.